Recent Quotes
My Watchlist
Indicators
Investor Uprising 25
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

910.39 +5.42 (+0.60%)
Streaming Delayed Price Updated: 1:26 PM EDT, Sep 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,099,880
Open 912.85
Bid (Size) 910.31 (2)
Ask (Size) 911.30 (4)
Prev. Close 904.97
Today's Range 903.86 - 913.82
52wk Range 516.57 - 972.53
Shares Outstanding N/A
Dividend Yield 0.50%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
2024 Election: Drug Prices Remain A 'Hot Topic.' Can Pharma Stocks Withstand The Pressure?
Pharma stock have been on the rise in the latter half of the year, but the 2024 election remains a wild card for shares. 
Via Investor's Business Daily
1 Unstoppable Stock That Could Join the $1 Trillion Club in 2025
Eli Lilly stock may look expensive, but that may not be the case in a few years as the business grows at a rapid pace. 
Via The Motley Fool

Performance

YTD
+53.73%
+53.73%
1 Month
-1.24%
-1.24%
3 Month
+2.75%
+2.75%
6 Month
+17.79%
+17.79%
1 Year
+58.34%
+58.34%

More News

Read More
Prediction: This Will be Eli Lilly's Next Big Move.
Via The Motley Fool
Why ResMed Stock Tumbled by 5% Today
Via The Motley Fool
This Small-Cap Stock Has a Promising GLP-1 Drug Which Could Rival Novo Nordisk and Eli Lilly's Weight-Loss Treatments
Via The Motley Fool
Looking Into Eli Lilly's Recent Short Interest
Via Benzinga
Unpacking the Latest Options Trading Trends in Eli Lilly
Via Benzinga
6 Incredible Reasons to Invest in Eli Lilly
Via The Motley Fool
ADX: A High-Yielding, Diversified CEF Worth Looking Into
Via Talk Markets
Prediction: This Will Be the First Healthcare Stock to Join the Trillion-Dollar Club
Via The Motley Fool
1 Telemedicine Stock I Wouldn't Touch With a 10-Foot Pole (Hint: It's Not Teladoc)
Via The Motley Fool
Eli Lilly Scores FDA Approval For Eczema Treatment Ebglyss
Via Benzinga
Exposures Product Safety
Kalm Therapeutics Hires Former GSK Director Dr. Tomoko Maeda-Chubachi as Chief Medical Officer
Via Newsfile
Looking At Eli Lilly's Recent Unusual Options Activity
Via Benzinga
Unpacking the Latest Options Trading Trends in Eli Lilly
Via Benzinga
3 Stocks to Buy and Hold Forever
Via The Motley Fool
Time To Invest And Or Trade In Bio-Tech Stocks?
Via Talk Markets
Topics ETFs
Stock Market Rally Revives; Apple iPhone 16, Nvidia, Oracle, Adobe In Focus: Weekly Review
Via Investor's Business Daily
Eli Lilly Pumps $800M Into Irish Operations To Meet Skyrocketing Demand For Mounjaro, Zepbound
Via Benzinga
Forget Eli Lilly and Novo Nordisk: This Could Be the Best Weight Loss Stock to Buy Right Now
Via The Motley Fool
3 No-Brainer Biotech Stocks to Buy With $200 Right Now
Via The Motley Fool
Why Roche Holdings Stock Withered on Wednesday
Via The Motley Fool
Why Viking Therapeutics Stock Rocked the Market Today
Via The Motley Fool
Harvest ETFs (TSX: LLYH, LLYH.U, AMZH, AMZH.U, MSFH, MSFH.U, NVDH, NVDH.U, LLHE, LLHE.U, AMHE, AMHE.U, MSHE, MSHE.U, NVHE, NVHE.U ) Closes the Market
Via Newsfile
Topics ETFs
4 No-Brainer Stock Splits to Buy Now
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.